Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Le Lézard4m
BirdseyePost Unveils Penny©, a Fully Autonomous AI Agent for Scalable, Data-Driven Marketing Across Print and Digital
BirdseyePost announces groundbreaking features in its autonomous marketing platform, enabling businesses of all sizes and sectors to rapidly launch targeted direct mail campaigns across North America.
Le Lézard4m
NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics, Inc. ("NeoGenomics" or the "Company") , a leading oncology testing services company, today announced the Company will participate in the following investor conferences: TD Cowen 45th ...